EDGAR Filing Documents for 0001144204-14-040327

Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:

SEC Accession No. 0001144204-14-040327

Filing Date

2014-06-30

Accepted

2014-06-30 13:55:16

Documents

Period of Report

2014-03-31

Document Format Files

Seq	Description	Document	Type	Size
1	ANNUAL REPORT	v381997_10k.htm	10-K	1257120
2	EXHIBIT 21	v381997_ex21.htm	EX-21	1483
3	EXHIBIT 23	v381997_ex23.htm	EX-23	3389
4	EXHIBIT 31.1	v381997_ex31-1.htm	EX-31.1	9028
5	EXHIBIT 31.2	v381997_ex31-2.htm	EX-31.2	9019
6	EXHIBIT 32.1	v381997_ex32-1.htm	EX-32.1	4596
7	EXHIBIT 32.2	v381997_ex32-2.htm	EX-32.2	4586
	Complete submission text file	0001144204-14-040327.txt		11163323

Data Files

Seq	Description	Document	Type	Size
8	XBRL INSTANCE DOCUMENT	eltp-20140331.xml	EX-101.INS	1949052
9	XBRL TAXONOMY EXTENSION SCHEMA	eltp-20140331.xsd	EX-101.SCH	98694
10	XBRL TAXONOMY EXTENSION CALCULATION LINKBASE	eltp-20140331_cal.xml	EX-101.CAL	64057
11	XBRL TAXONOMY EXTENSION DEFINITION LINKBASE	eltp-20140331_def.xml	EX-101.DEF	407492
12	XBRL TAXONOMY EXTENSION LABEL LINKBASE	eltp-20140331_lab.xml	EX-101.LAB	523760
13	XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE	eltp-20140331_pre.xml	EX-101.PRE	507839

Mailing Address 165 LUDLOW AVENUE NORTHVALE NJ 07647

Business Address 165 LUDLOW AVENUE NORTHVALE NJ 07647 2017502646

ELITE PHARMACEUTICALS INC /NV/ (Filer) CIK: 0001053369 (see all company filings)